Changes in Characteristics of Patients Initiating and Discontinuing Advanced Therapies for Rheumatoid Arthritis Following the Release of Safety Data.
Stephanie SongBryant R EnglandBrian C SauerMichael D GeorgeThomas R RileyBeth WallaceGrant W CannonTed R MikulsJoshua F BakerPublished in: Arthritis care & research (2023)
Recent safety data significantly affected prescribing practices for advanced therapies, with a reduction in JAKi initiation and an increase in JAKi discontinuation among older patients and those at high cardiovascular risk. This article is protected by copyright. All rights reserved.
Keyphrases
- rheumatoid arthritis
- primary care
- end stage renal disease
- electronic health record
- chronic kidney disease
- ejection fraction
- big data
- newly diagnosed
- healthcare
- prognostic factors
- peritoneal dialysis
- emergency department
- disease activity
- patient reported outcomes
- ankylosing spondylitis
- systemic lupus erythematosus
- artificial intelligence
- idiopathic pulmonary fibrosis
- patient reported